Back to Search
Start Over
427 Plasma and urinary pharmacokinetics of the novel, oral SHIP1 activator, AQX-1125 in interstitial cystitis/bladder pain syndrome (IC/BPS): Results of the phase2 LEADERSHIP trial.
- Source :
-
European Urology Supplements . Mar2016, Vol. 15 Issue 3, pe427-e427. 1p. - Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 15699056
- Volume :
- 15
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- European Urology Supplements
- Publication Type :
- Academic Journal
- Accession number :
- 113541015
- Full Text :
- https://doi.org/10.1016/S1569-9056(16)60429-3